Hygea Medical is a National High-tech Enterprise specializing in the field of Interventional Oncology, focusing on percutaneous and transvascular interventions. The company's flagship product, the Co Ablation System, integrates cryoablation and hyperthermia ablation into a single system, making it a pioneering solution in the industry. This system has received the CE Marking Certificate and is marketed across European countries. The Co Ablation System AI Epic series has also won the prestigious iF DESIGN AWARD 2020. Hygea Medical operates a Beijing Key Laboratory of Cryogenic Biomedical Engineering and a Post-Doctoral Research Center, and holds over 150 patents globally. The company serves hospitals and medical institutions, providing advanced solutions for minimally invasive tumor treatments. Its business model revolves around the research, development, production, and sales of cutting-edge medical technologies, generating revenue through product sales and strategic partnerships.

Keywords: Interventional Oncology, Cryoablation, Hyperthermia, Minimally Invasive, Tumor Treatment, High-tech, Patents, Medical Innovation, CE Marking, Research Center.